Ulcer Prevention Study in Post Gastric Bypass Patients

NCT00557349 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Marginal Ulcers

Interventions

DRUG: Omeprazole
DRUG: Famotidine

Sponsor

University of Missouri-Columbia